Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findingsNeil A. Goldenberg, Ayesha Zia, Craig M. Kessler et al.|Journal of Thrombosis and Haemostasis|2015Cited by 66
The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn Malec, Margaret V. Ragni, Dunlei Cheng et al.|American Journal of Hematology|2020Cited by 31
Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United StatesLynn Malec, Margaret V. Ragni, Char Witmer et al.|Blood|2018Cited by 2